Introduction. The Metabolic Syndrome (MS) is the modern pandemic both developed, and developing countries. The MS acts as risk factor of development of cardiovascular accidents, insulin resistance and an hypogonadism.
Research objective: searching of correlations of a metabolic syndrome with a syndrome of chronic pelvic pain and violation of a miktion at men.
Objective: to develop an algorithm for screening hypogonadism for men undergoing medical examination to detect diseases of the prostate.
Materials and methods: the study involved 454 people with various diseases of the prostate gland (benign prostatic hyperplasia, chronic prostatitis, prostate cancer), which are randomly selected for the study during an outpatient admission. In the future, patients underwent a comprehensive urological examination. Hypogonadism was defined as testosterone concentration <12 nmol/l.
Results and discussion: hypogonadism was diagnosed in 196 (43.2%) patients, which is close to the indicators of foreign statistics. Such a high prevalence of VAD, as well as its apparent prevalence in men from 50 to 79 years (165 – 84%) of patients with hypogonadism, suggest the need for mandatory androgen screening in men after 50 years. In patients with androgen deficiency prostate cancer is also significantly more common.
Conclusions: screening for age-related androgen deficiency should be routine after 50 years, as hypogonadism is an aggravating factor in the course of prostate diseases.
Authors declare lack of the possible conflicts of interests